パンデミック期間中の抗うつ薬と抗不安薬の全国的な使用:トルコにおけるCOVID-19 パンデミック期間中の薬物使用傾向 (PANDUTI-TR) 研究の結果
Caner Vizdiklar1,2, Volkan Aydin3,4, Hakan Yilmaz5
1Department of Medical Pharmacology, Marmara University School of Medicine, Istanbul 34854, Turkey.
Family practice
|September 5, 2025
まとめ
COVID-19 パンデミックでは,抗うつ薬と抗不安薬の使用が増加し,精神保健薬剤療法の必要性が高まっていることが示されました. パンデミックと規制後の期間中,消費は著しく増加しました.
科学分野:
- 薬理学と公衆衛生
- 精神衛生の流行病学
背景:
- COVID-19の流行は,精神疾患の増加と関連しています.
- この急増は抗うつ薬と抗不安薬の消費パターンに 潜在的に影響を与えた.
研究 の 目的:
- COVID-19 パンデミック中の抗うつ薬と抗不安薬の利用の変化を評価する.
- パンデミック各段階における薬物消費と支出の傾向を分析する.
主な方法:
- IQVIA Turkey (2018年3月 - 2022年12月) の全国的な薬物販売と処方データを活用した.
- 定義された日用量 (DID) を用いて推定された月間平均消費と支出
- 3つの期間を比較した. 制限前の (BfR), 制限中の (DuR), 制限後の (AfR).
主要な成果:
- 抗うつ薬の消費量は47. 9 DID (BfR) から60. 5 DID (AfR) に増加した (P < . 001).
- 抗不安薬の使用量は2. 0 DID (BfR) から2. 7 DID (AfR) に増加した (P < .001).
- 両方の薬剤の支出は増加したが,処方傾向は最初は減少し,その後は変動した.
結論:
- 抗うつ薬と抗不安薬の使用の持続的な増加は,流行後の発症が観察されました.
- これは,うつ病や不安障害の薬剤療法に対する需要が増加していることを示唆しています.
- 精神的健康への負担が大きくなっていることが分かりました 特に不安障害の場合です
関連する概念動画
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
562
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
562
Antidepressant Drugs: Overview
736
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
736
Antidepressant Drugs: MAOIs and Other Agents
337
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
337
Anxiolytic Drugs: Overview
479
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
479
Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
Anxiolytic Drugs: Benzodiazepines and Buspirone
1.2K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.2K


